Mingning Ding
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy.
Journal: Journal of ethnopharmacology
Published: March 19, 2024
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead.
Journal: Acta pharmaceutica Sinica. B
Published: July 01, 2023
Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN.
Journal: Chinese journal of natural medicines
Published: March 17, 2023
Chuanxiong Rhizoma extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway.
Journal: Chinese herbal medicines
Published: March 01, 2023
Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 01, 2022
Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 26, 2022
Cassiae Semen improves non-alcoholic fatty liver disease through autophagy-related pathway.
Journal: Chinese herbal medicines
Published: March 07, 2022
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways.
Journal: Frontiers in pharmacology
Published: December 01, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026